Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3
- 31 December 1991
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 126-131
- https://doi.org/10.1016/0277-5379(91)90468-s
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Haptoglobin-Related Protein (Hpr) Epitopes in Breast Cancer as a Predictor of Recurrence of the DiseaseNew England Journal of Medicine, 1989
- Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancerJournal of Molecular Medicine, 1989
- Zur Wertigkeit der Tumormarker CA 15-3 und CEA beim MammakarzinomArchiv für Gynäkologie, 1989
- A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerCancer, 1989
- Pretreatment Concentrations of Breast Carcinoma Antigen (CA 15.3) and Mucin-Like Carcinoma-Associated Antigen in Patients with Carcinoma of the BreastTumor Biology, 1989
- Tumormarker bei Mammakarzinom: Zur diagnostischen Wertigkeit von Serumbestimmungen bei klinischer Tumorfreiheit (NED) und manifester ErkrankungOncology Research and Treatment, 1989
- High molecular weight epithelial mucins as markers in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- CA 15-3 und CEA als Tumormarker zur Rezidivdiagnostik beim MammakarzinomGeburtshilfe und Frauenheilkunde, 1988
- Monoclonal antibodies against antigens on breast cancer cellsCellular and Molecular Life Sciences, 1985